课题基金 / 基金详情

Gene expression network for tumor suppression

Gene expression network for tumor suppression
抑制肿瘤的基因表达网络
批准号:
12219204
负责人:
TANIGUCHI Tadatsugu
金额:
$261.06万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2004

项目摘要

项目成果

TANIGUCHI Tadatsugu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the current study, we have made multifaceted approach to elucidate molecular mechanisms for oncogenesis, by analyzing not only the interrelationships between molecules which are involved in tumor suppression but also the gene expression network from both genetic and epigenetic aspects. Specifically, we found several important roles of "weak signal" by constitutively produced IFN-α/β in IFN-γ or IL-6-mediated cellular response as well as regulatory systems for cancer prevention. We also found a novel cross-talk mechanism between RANKL and IFN-γ, and clarified the regulatory role of the IFN system in osteoclast differentiation, which provided its putative therapeutic application to bone destruction by metastatic tumors. Development of autoimmune-like disease was observed in mice lacking IRF-2, which is an attenuator of IFN-a/β signaling. Further analyses revealed the role of IFN-α/β signaling in the regulation of CD8^+ T cell response. In these IRF-2-deficient mice, such hyperactivati … More on of IFN-α/β signaling affects normal differentiation of dendritic cells. IFN-α/β signaling is also found to be indispensable during DC maturation. Furthermore, it was demonstrated that another IRF-family member, IRF-7, is an essential transcriptional factor for the IFN induction in plasmacytoid DCs in response to unmethylated DNA (CpG), which is known to be a potent adjuvant for anti-tumor immunity. And we found a spaciotemporal regulation, by which plasmacytoid DCs are capable to produce IFN-α/β at high levels. On the other hand, IRF-5 is also found to be essentially involved in the CpG-induced production of proinflammatory cytokines. In addition, we identified novel p53 target genes, Noxa and Reprimo, which are involved in p53-mediated apoptosis or cell cycle arrest, respectively. Further study by generating Noxa-deficient mice revealed that Noxa may be a beneficial therapeutic target since it undergoes selective apoptosis in oncogene-expressing cells. Finally, we found an interrelationship between IFN-α/β signaling and p53-mediated response, which provided a novel aspect in terms of a linkage between tumor suppression and immunity.Taken together, we believe that these research accomplishments contribute to some advance in understanding molecular mechanisms underlying tumor suppression, and provide a molecular basis for their clinical applications. Less
期刊论文(88)
专著(0)
科研奖励(0)
会议论文
Noxa, a BH3-only member of the Bcl-2 family, and candidate mediator of p53-induced apoptosis.
Noxa 是 Bcl-2 家族中仅包含 BH3 的成员,也是 p53 诱导的细胞凋亡的候选介质。
DOI: --
发表时间: 2000
期刊: Science 288
影响因子: --
作者: [Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., Tanaka, N.]
通讯作者: N.
Sato,M.: "The IFN system and IRF transcription factors ; studies from gene knockout mice."Cytokine Growth Factor Rev.. (in press). (2001)
Sato,M.:“IFN 系统和 IRF 转录因子;基因敲除小鼠的研究。”《细胞因子生长因子 Rev.》(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Honda, K., Sakaguchi, S., Nakajima, C., Watanaba, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., Seya, T., Taniguchi, T.: "Selective contribution of IFN-α/β signaling to the maturation of dendritic cells induced by double-st
Honda, K.、Sakaguchi, S.、Nakajima, C.、Watanaba, A.、Yanai, H.、Matsumoto, M.、Ohteki, T.、Kaisho, T.、Takaoka, A.、Akira, S.、 Seya, T., Taniguchi, T.:“IFN-α/β 信号传导对双链诱导的树突状细胞成熟的选择性贡献
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
40
    Innate immune system activation and regulation via DNA receptors.
    • 批准号:
      19209016
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.2万
    • 财政年份:
      2007
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    Informatory expression system connecting cancer and immunity.
    • 批准号:
      17012005
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $267.01万
    • 财政年份:
      2005
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    New Frontiers of Cancer Sciences
    • 批准号:
      17012004
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $5.38万
    • 财政年份:
      2005
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    Advanced research on cancer
    • 批准号:
      11182101
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $77.95万
    • 财政年份:
      1999
    • 负责人:
      TANIGUCHI Tadatsugu
    • 依托单位:
    海外基金